Hyderabad, Aug. 02, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Sarcopenia Treatment Market Report (2023-2028)," the market is estimated at USD 3.01 billion in 2023. It is expected to register a CAGR of 4.58% during the forecast period.
Sarcopenia is described as the loss of muscle mass, function, and strength associated with aging. There are no FDA-approved medications for treating sarcopenia. Key players are focusing on research on sarcopenia treatment.
Report Summary:
| Report Attribute | Details |
| Market Size (2023) | USD 3.01 billion |
| Market Size (2028) | USD 3.76 billion |
| CAGR (2023-2028) | 4.58% |
| Study Period | 2018-2028 |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Forecast Units | Value (USD billion) |
| Report Scope | Market Dynamics, Revenue Forecast and Segmentation, Competitive Landscape, and Recent Developments, Market Growth, Future Opportunities, and Trends |
| Key Market Drivers | The rise in the geriatric population and malnutrition. |
| Increasing musculoskeletal problems acquired by patients post-COVID-19. |
Who are the Top Companies in the Sarcopenia Treatment Market?
The market is moderately competitive in nature. The key players are focused on strengthening their portfolios for treating sarcopenia.
Significant players in the sarcopenia treatment market are,
- Abbott Nutrition
- GSK PLC
- Nestle Health Science
- Sanofi SA
- Bayer AG
- Novartis AG
- Metagenics LLC
- Wellona Pharma
- Intas Pharmaceuticals Ltd
- Perrigo Company PLC
- Dr. Jockers Store
Other Reports That Might Be of Your Interest:
- Diabetic Foot Ulcer Treatment Market Report - The diabetic foot ulcer treatment market is expected to register a CAGR of 5.90% during the forecast period (2023-2028).
- Sinusitis Treatment Market Report - The sinusitis treatment market is expected to register a CAGR of 6.40% during the forecast period (2023-2028).
Key Highlights from the Sarcopenia Treatment Market Report:
Demand for Protein Supplements to Drive the Market
- Protein is critical to maintaining normal bodily functions. Daily protein intake is, thus, essential to maintaining muscle mass and strength. Therefore, including protein in diets prevents the loss of muscle mass, thereby driving the market.
- The increasing R&D activities are helping identify the protein usage needed to fulfill the protein deficiency and treat sarcopenia, thus, driving the segment.
North America to Hold Significant Market Share
- North America is expected to hold a significant market share due to the presence of developed healthcare facilities and technological developments.
- Various initiatives by the government are supporting the research and development of sarcopenia treatments, driving the growth of the market in the region.
What are the Latest Developments in the Sarcopenia Treatment Market?
- In July 2023, Biophytis applied for approval from the US FDA to launch SARA-31, which is expected to be the first Phase II study in sarcopenia.
- In February 2023, University College Dublin started a clinical trial to study the efficiency of a 12-week resistance exercise program with or without an oral nutritional supplement.
Mordor Intelligence has Segmented the Sarcopenia Treatment Market Based on Treatment Type, Distribution Channel, and Geography:
- By Treatment Type (Market Size and Forecast based on Value (USD billion), 2018-2028)
- Protein Supplements
- Vitamin B12 Supplements
- Vitamin D and Calcium Supplements
- Other Treatment Types
- By Distribution Channel (Market Size and Forecast based on Value (USD billion), 2018-2028)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- By Geography (Market Size and Forecast based on Value (USD billion), 2018-2028)
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
In a nutshell, the Mordor Intelligence market research report is a must-read for start-ups, industry players, investors, researchers, consultants, business strategists, and all those who are looking to understand this industry. Get a glance at the Sarcopenia Treatment Market Report (2023-2028).
Mordor Intelligence constantly tracks industry trends. Some relevant market reports from the analysts that might be of interest to you:
- Chronic Myelogenous Leukemia Treatment Market Report - The chronic myelogenous leukemia treatment market is expected to register a CAGR of 5.30% during the forecast period (2023-2028).
- Allergy Treatment Market Report - The allergy treatment market size is estimated at USD 19.47 billion in 2023. It is expected to reach USD 28.74 billion by 2028, registering a CAGR of 8.10% during the forecast period (2023-2028).
- Rare Disease Treatment Market Report - The rare disease treatment market size is estimated at USD 193.56 billion in 2023. It is expected to reach USD 340.05 billion by 2028, with a CAGR of 11.93% during the forecast period (2023-2028).
About Mordor Intelligence:
Mordor Intelligence is a market intelligence and advisory firm. At Mordor Intelligence, we believe in predicting butterfly effects that have the potential to change or significantly impact market dynamics.
Our market research reports are comprehensive and provide exclusive data, facts and figures, trends, and the competitive landscape of the industry.
Attachment
